论文部分内容阅读
在全球范围广泛使用麻疹减毒活疫苗(Measles Attenuated Live Vaccine,MV)前的1980年,估算全球共发生260万麻疹死亡病例。2001年,为促进通过接种MV降低麻疹发病的效果,世界卫生组织(WHO)和联合国儿童基金会(UNICEF)建立了通过常规免疫接种服务和强化免疫活动(Supplementary Immunization Activities,SIAs),为每名儿童接种2剂含麻疹成分疫苗(Measles-containing Vaccine,MCV)的策略,并改善了疾病监测系统。该策略实施后,全球每年估算麻疹死亡数从2000年的73.3万例减少至2008年的16.4万例。20102015
In 1980, prior to the widespread use of Measles Attenuated Live Vaccine (MV) worldwide, an estimated 2.6 million measles deaths worldwide were reported. In 2001, to help reduce the incidence of measles by vaccination, the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) established a program for routine immunization services and supplementary immunization activities (SIAs) Children received two doses of Measles-containing Vaccine (MCV) strategies and improved disease surveillance systems. After the implementation of this strategy, the annual estimated global measles deaths decreased from 733,000 cases in 2000 to 164,000 cases in 2008. 20102015